Insider buying last 90 days
No open-market insider purchases were filed for BKD in the last 90 days.
From Form 4 filings, dated to when each was filed.
Oct 12 close
Brookdale Senior Living moves this week on a string of third-quarter occupancy updates. The company reported weighted average consolidated occupancy reaching 83.1% in the third quarter, a 130 basis point year-over-year increase, with month-end occupancy reaching 84.6% and sequential gains of 70 basis points both consolidated and same-community. Despite the year-over-year and sequential improvement, shares slid 5.9% after the September occupancy update, as the figures reportedly fell slightly below market expectations, with RBC Capital Markets noting the sequential pace was slower than anticipated.
The stock closes at $10.24, up 1.2%, but remains below both its 50-day average of $11.94 and 200-day average of $13.39, with the 50-day below the 200-day. Returns are negative over one month (-15.7%) and three months (-27.8%), though still positive over one year (15.3%). The GekkoIndex reads 72.1, placing BKD in the Buying zone. Price sits 22.6% below Gekko Fair Value of $13.23.
Over the next 20 trading days, earnings are due 5 November 2026 after close, 24 days away, falling inside a typical holding window and following a prior reaction of -11.7% after the last report. No insider, Congress or unusual options activity appears in their respective 90-day and 30-day windows. Seasonality from this point in the calendar has averaged +5.8% over the next 20 trading days across 5 years, rising in 4 of them. Analyst coverage from 4 firms stands at 4 buy ratings, with a consensus target of $19.25.
Written by AI from the Oct 12, 2026 close and checked automatically against the figures on this page.
Brookdale Senior Living scores 3 supportive, 0 mixed and 2 headwinds across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
3 supportive0 mixed2 headwinds
Below 50 and 200-day
Close $10.24 is below the 50-day ($11.94) and 200-day ($13.39) averages, and the 50-day is below the 200-day.
See the chart72.1, Buying
Reading 72.1 is in the Buying zone.
See the GekkoIndex22.6% below
Price is 22.6% below Gekko Fair Value (more than 5% below).
See fair valueNo data
No insider, Congress or unusual options activity in the window.
See smart moneyReports in 24 days
Reports on Nov 5, 2026, 24 days away — inside a typical 20-trading-day hold.
See earnings+5.8% on average
From this point in the calendar, the next 20 trading days averaged +5.8% over 5 years, rising in 4 of them.
See seasonalityA description of current data, not a recommendation. How this page works
Brookdale Senior Living closed at $10.24 on Oct 12, 2026, +15.3% over the past year, inside a 52-week range of $8.02 to $17.09.
Use the left and right arrow keys to read daily values.
Put BKD on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Brookdale Senior Living’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 72.1, in the Buying zone, down 3.9 points over five sessions.
Down 3.9 points over five sessions.
Reading for Oct 12, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying (current zone) | 50 | +1.2% | +1.5% | ||
| Accumulation | 210 | +0.3% | +1.3% | ||
| Neutral | 346 | +0.7% | +4.1% | ||
| Distribution | 75 | +0.9% | +1.0% | ||
| Selling | 1 | Too few readings yet | |||
Average BKD share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Buying readings averaged +3.1% over 20 days. Past behaviour doesn’t guarantee future results.
Buying zone: Smart money likely accumulating heavily. About the five zones →
Brookdale Senior Living trades 22.6% below Gekko Fair Value of $13.23, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Brookdale Senior Living shares are worth, recalculated every trading day.
$13.23
Gekko Fair Value, Oct 9, 2026
22.6% Undervalued
At the end of Aug 2026 the price was 37.9% below the estimate.
No open-market insider purchases were filed for Brookdale Senior Living, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for BKD in the last 90 days.
From Form 4 filings, dated to when each was filed.
No trades in BKD were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Brookdale Senior Living has been buying back its own shares.
From company filings.
2of the funds Gekko tracks hold BKD.
Brookdale Senior Living reports on Nov 5, 2026, after the close (24 days away), and beat the EPS estimate in 2 of its last 8 reports.
Nov 5, 2026
Expected after the close, 24 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Aug 10, 2026 | $0.10 est −$0.04 | $718.6M est $735.6M | −11.7% |
| May 6, 2026 | −$0.02 est −$0.09 | $764.9M est $771.2M | −3.3% |
| Feb 18, 2026 | −$0.17 est −$0.16 | $754.1M est $766.3M | −10.2% |
| Nov 6, 2025 | −$0.20 est −$0.18 | $777.8M est $770.5M | +1.7% |
| Aug 6, 2025 | −$0.16 est −$0.14 | $812.9M est $817.6M | −9.5% |
| May 6, 2025 | −$0.28 est −$0.14 | $813.9M est $816.9M | −0.3% |
| Feb 18, 2025 | −$0.27 est −$0.24 | $780.9M est $781.8M | +2.4% |
| Nov 7, 2024 | −$0.22 est −$0.17 | $784.2M est $784.2M | −14.9% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Brookdale Senior Living is $19.25, +88.0% from the last close, from 4 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 4 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Oct 9 | Barclays | $17 | +66.0% |
| Sep 30 | Bank of America Securities | $19.50 | +90.4% |
| Sep 23 | Bank of America Securities | $19.50 | +90.4% |
| Sep 17 | Jefferies | $23 | +124.6% |
| Sep 10 | Barclays | $17 | +66.0% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Oct 10, Brookdale Senior Living averaged +5.8% across the last 5 years, rising in 4 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +2.8% | 3 of 5 |
| Next 10 trading days | −1.2% | 2 of 5 |
| Next 15 trading days | +1.8% | 2 of 5 |
| Next 20 trading days | +5.8% | 4 of 5 |
| Next 30 trading days | +1.4% | 2 of 5 |
For scale, BKD’s typical 20-trading-day move in either direction is about 8.1%.
Brookdale Senior Living’s market cap is $2.45B and revenue of $2.93B over the last twelve months.
Coverage of Brookdale Senior Living this week reads positive: 7 positive, 3 neutral and 3 negative headlines.
Brookdale Senior Living’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| HCAHCA Healthcare | Neutral | 18.9% above |
| THCTenet Healthcare | Neutral | 6.7% below |
| UHSUniversal Health Services | Neutral | 21.4% below |
| PACSPACS | Neutral | 11.0% below |
| CHEChemed | Accumulation | 7.7% below |
| NHCNational HealthCare | Neutral | 30.5% above |
A peer links to its own page where one exists.
Brookdale Senior Living’s market cap is $2.45B at the Oct 12, 2026 close of $10.24, with 238.8M shares outstanding.
The consensus analyst 12-month price target for Brookdale Senior Living is $19.25, +88.0% from the last close. Of the 4 firms that rated the stock in the last 90 days, 4 rate it a buy, 0 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Brookdale Senior Living is undervalued: the Oct 12, 2026 close of $10.24 is 22.6% below Gekko Fair Value of $13.23. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Brookdale Senior Living is expected to report on Nov 5, 2026, after the market closes (24 days away). Analysts expect earnings of −$0.03 per share on revenue of $721.8M. Brookdale Senior Living beat the earnings estimate in 2 of its last 8 reports, moving 6.7% on average across the report.
Brookdale Senior Living’s 52-week high is $17.09 and its 52-week low is $8.02; it closed at $10.24 on Oct 12, 2026, +15.3% over the past year.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 5 items with data read as supportive (gekkoindex, fair value and seasonality) and 2 as headwinds (trend and earnings risk). The checklist is a description of current data, not a recommendation.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,408 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.